Musso Alan A 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jan 5, 2018
Insider Transaction Report
Form 4
Musso Alan A
CFO and Treasurer
Transactions
- Exercise/Conversion
Common Stock
2018-01-03+1,875→ 33,460 total - Tax Payment
Common Stock
2018-01-03$9.79/sh−706$6,912→ 32,754 total - Exercise/Conversion
Restricted Stock Units
2018-01-03−1,875→ 5,625 total→ Common Stock (1,875 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of BLCM common stock.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2018, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 7,500 shares.
- [F3]On January 3, 2017, the reporting person was granted 7,500 RSUs, of which 1,875 vested on January 3, 2018. The RSUs vest in four equal annual installments beginning January 3, 2018.